Table 1. FACS antibodies.
| Target | Clone | Supplier |
|---|---|---|
| Mouse | ||
| CD45 BV711 | 30-F11 | BioLegend |
| CD45-BV605 | 30-F11 | BioLegend |
| CD3-BV650 | 17A2 | BioLegend |
| CD4-AF700 | RM4-5 | BioLegend |
| CD8-APCeF780 | 53-6.7 | eBioscience |
| CD19-PE/CF594 | 1D3 | BD Biosciences |
| NK1.1-BV421 | PK136 | BioLegend |
| NK1.1-PerCP/Cy5.5 | PK136 | BioLegend |
| IFNγ-PerCP/Cy5.5 | XMB1.2 | BioLegend |
| GzmB-FITC | QA16A02 | BioLegend |
| GzmB-PE/Cy7 | NGZB | eBioscience |
| Ki-67-eF450 | SolA15 | eBioscience |
| CXCR3-APC | CXCR3-173 | BioLegend |
| CD98-BV605 | H202-141 | BD Biosciences |
| CD98-PE | H202-141 | BD Biosciences |
| PD-1-BV785 | 29F.1A12 | BioLegend |
| PD-1-BV711 | 29F.1A12 | BioLegend |
| PD-1-PE/Dazzle594 | RMP1-30 | BioLegend |
| pS6-PE | D57.2.2E | Cell Signaling Technology |
| pS6-PE/Cy7 | D57.2.2E | Cell Signaling Technology |
| CD44-BV605 | IM7 | BioLegend |
| CD62L-PE/CF594 | MEL-14 | eBioscience |
| PD-L1-APC | 10F.9G2 | BioLegend |
| TIM-3-BV421 | RMT3-23 | BioLegend |
| LAG-3-eF780 | C9B7W | eBioscience |
| TIGIT-APC | 1G9 | BioLegend |
| CD244.2-PE | m2B4 (B6)458.1 | BioLegend |
| TCF1/TCF7-AF647 | C63D9 | Cell Signaling Technology |
| TOX-PE | REA473 | Miltenyi Biotec |
| Eomes-eF450 | Dan11mag | BioLegend |
| T-bet-PECF594 | O4-46 | BD Biosciences |
| TNF-BV785 | MP6-XT22 | BioLegend |
| Human | ||
| CD3-AF700 | UCHT1 | BioLegend |
| CD4-APC | A161A1 | BioLegend |
| CD8-BV605 | SK1 | BioLegend |
| CD19-APC/Cy7 | HIB19 | BioLegend |
| CD56-BV650 | 5.1H11 | BioLegend |
| IFNγ-PE-CF594 | B27 | BD Biosciences |
| GzmB-FITC | GB11 | BioLegend |
| TNF-BV421 | MAb11 | BioLegend |
| LAG-3-PE | 11C3C65 | BioLegend |
| PD-1-PE-eF610 | J105 | eBioscience |
| TIGIT-PerCP-Cy5.5 | MBSA43 | BioLegend |
| TIM-3-BV785 | F38-2E2 | BioLegend |